Patent Grant
11802318
Not applicable.
Synthetic biology unites biology and engineering with a focus on constructing novel biomolecular components, complex synthetic networks, and unnatural metabolic pathways in living cells.
RNA based components are an attractive means to construct more complex circuits since they can take advantage of predictable Watson-Crick base pairing and exploit the numerous RNA based gene regulation systems that have been found in nature. Indeed, researchers have created many engineered RNA riboregulators based on natural systems that regulate transcription or translation upon detection of a target RNA. However, these systems have been limited in their dynamic range and their orthogonality. More recently, de-novo-designed riboregulators called toehold switches and small trans-activating RNAs have been developed that offer markedly improved performance compared to riboregulators inspired by natural systems. In particular, synthetic riboregulators can be activated by a wider range of RNA sequences, enabling improved device orthogonality, and they provide much larger dynamic range, which can lead to ON/OFF ratios above 100-fold. Despite these advantages, toehold switches do suffer from a number of important limitations. First, they exhibit noticeable signal leakage, which limits their use in applications requiring very stringent regulation of gene expression. Second, they have limited sequence discrimination capabilities precluding single nucleotide polymorphism (SNP) detection. Third, they impose restrictions on the sequence of the target RNA to be detected and the residues incorporated into the output gene. Accordingly, there remains a need in the art for improved synthetic riboregulators able to detect truly arbitrary RNAs without affecting the sequence of the output gene.
In a first aspect, provided herein is a loop-mediated riboregulator comprising a synthetic nucleic acid molecule, the synthetic nucleic acid molecule comprising
In another aspect, provided herein is a method of detecting presence of an RNA in a sample, the method comprising contacting to a sample a loop-mediated riboregulator as provided herein comprising a trigger recognition sequence that is fully or partially complementary to an endogenous RNA and a coding domain that encodes a reporter protein, wherein contacting occurs under conditions that allow translation of the reporter protein in the presence of the endogenous RNA but not in the absence of the endogenous RNA; and detecting the reporter protein as an indicator of the endogenous RNA in the sample. The sample can be a biological sample. Detecting the endogenous RNA molecule can be a positive indicator of a presence of a microorganism, pathogen, or gene in said sample. The microorganism or pathogen can be selected from the group consisting of HIV, Zika virus, norovirus, Yellow fever virus, and Plasmodium falciparum. Detecting the endogenous RNA molecule can be a negative indicator of a presence of a microorganism, pathogen, or gene in said sample. The microorganism or pathogen is selected from the group consisting of HIV, Zika virus, norovirus, Yellow fever virus, and Plasmodium falciparum.
In a further aspect, provided herein is a method of detecting presence of an RNA in a cell, the method comprising introducing into a cell a loop-mediated riboregulator as provided herein comprising a trigger recognition sequence that is fully or partially complementary to an endogenous RNA in the cell and a coding domain that encodes a reporter protein; culturing the cell under conditions that allow translation of the reporter protein in the presence of the endogenous RNA but not in the absence of the endogenous RNA; and detecting the reporter protein as an indicator of the endogenous RNA in the cell.
In another aspect, provided herein is a method for altering expression of a gene product in a cell, the method comprising introducing into a cell a sequence encoding a target gene product operably linked to a loop-mediated riboregulator, wherein the riboregulator comprises a trigger recognition sequence that is fully or partially complementary to a cognate trigger RNA; and wherein, in the presence of the cognate trigger RNA is present in the cell, expression of the gene product is altered. The fold-change in expression of the target gene product can be at least 25 fold. The fold-change in expression of the target gene product can be at least 50 fold. In the absence of the cognate trigger RNA, OFF state expression levels of the target gene product can be unchanged relative to a cell into which the loop-mediated riboregulator is not introduced. The loop-mediated riboregulator can be a loop-mediated repressor and expression of the target gene product is reduced relative to a cell into which the loop-mediated repressor is not introduced. The reduction can be at least 50-fold. The reduction can be at least 80-fold. Detecting the endogenous RNA molecule can be a positive indicator of a presence of a microorganism, pathogen, or gene in said sample. The microorganism or pathogen can be selected from the group consisting of HIV, Zika virus, norovirus, Yellow fever virus, and Plasmodium falciparum. Detecting the endogenous RNA molecule can be a negative indicator of a presence of a microorganism, pathogen, or gene in said sample. The microorganism or pathogen is selected from the group consisting of HIV, Zika virus, norovirus, Yellow fever virus, and Plasmodium falciparum.
In another aspect, provided herein is a synthetic nucleic acid logic circuit comprising a branched secondary structure comprising a stem-domain, a ribosomal binding site, a start codon and two or more loop-domains, wherein each loop-domain comprise a unique input RNA recognition site. The stem-domain can comprise the ribosomal binding site and the start codon. All of the loop mediated riboregulators described herein comprise a RBS and start codon located within a stem domain. Accordingly, the term “loop domain” as used herein encompasses a domain comprising a stem region plus a loop region. The 3′ most loop-domain of the branched secondary structure can comprise the ribosomal binding site and the start codon. The logic circuit can comprise three loop-domains and three unique input RNA recognition sites. The logic circuit can comprise four loop-domains and four input RNA recognition sites. The logic circuit can comprise five or more loop-domains and four or more unique input RNA recognition sites.
In another aspect, provided herein is a synthetic nucleic acid logic circuit comprising a branch secondary structure comprising two or more groups of loop-domains, wherein each group of loop-domains comprises two or more loop-domains, wherein each loop-domain comprises an input RNA recognition site, and wherein the 3′ most loop-domain of the branched secondary structure comprises a ribosomal binding site and a start codon. The logic circuit can be configured such that for translation to occur, one or more input RNA must be bound to the RNA recognition sites within each of the two or more groups of loop-domains. The logic circuit can comprise 2, 3, 4, 5, or more groups of loop-domains. Each group of loop-domains can comprise 2, 3, 4, 5, or more loop-domains.
The foregoing and other advantages of the invention will appear from the following description. In the description, reference is made to the accompanying drawings, which form a part hereof, and in which there is shown by way of illustration a preferred embodiment of the invention. Such embodiment does not necessarily represent the full scope of the invention, however, and reference is made therefore to the claims and herein for interpreting the scope of the invention.
This patent or application file contains at least one drawing executed in color. Copies of this patent or patent application publication with color drawing(s) will be provided by the Office upon request and payment of the necessary fee.
The present invention will be better understood and features, aspects, and advantages other than those set forth above will become apparent when consideration is given to the following detailed description thereof. Such detailed description makes reference to the following drawings, wherein:
While the present invention is susceptible to various modifications and alternative forms, exemplary embodiments thereof are shown by way of example in the drawings and are herein described in detail. It should be understood, however, that the description of exemplary embodiments is not intended to limit the invention to the particular forms disclosed, but on the contrary, the intention is to cover all modifications, equivalents and alternatives falling within the spirit and scope of the invention as defined by the appended claims.
All publications, including but not limited to patents and patent applications, cited in this specification are herein incorporated by reference as though set forth in their entirety in the present application.
The methods provided herein are based at least in part on the inventors' discovery of a new class of synthetic riboregulators known as “loop-mediated riboregulators” that can provide single-nucleotide polymorphism (SNP) sensitivity and ultralow OFF state signal levels. This new interaction mechanism enables loop-mediated riboregulators to detect truly arbitrary RNAs without affecting the sequence of the output gene. Furthermore, it enables them to regulate gene expression at both the transcriptional and translational level under certain conditions, which leads to devices with extremely low OFF state signal. As described in the paragraphs that follow and in the Examples section, testing of novel loop-mediated riboregulators in E. coli demonstrated that they provide a dynamic range of gene expression well over 100-fold and exhibit leakage levels nearly indistinguishable from cell auto-fluorescence. This disclosure, therefore, provides loop-mediated riboregulators and “devices” derived therefrom that offer greatly improved diversity, orthogonality, and functionality compared to previously described riboregulators.
Without being bound to any particular theory or mechanism of action, it is believed that the inventors addressed limitations associated with toehold switches using a novel loop-mediated interaction mechanism. Expression from the switch RNA is turned off initially because the ribosomal binding site (RBS) and start codons of the output gene are strongly concealed with the duplex of a stem-loop structure. When a target RNA binds to the large loop region of the mRNA, the repressing stem-loop structure is disrupted, exposing the ribosome binding site and initial codons of the output gene and enabling translation of the downstream gene. As described in the following paragraphs and the Examples section, the loop-mediated riboregulators provided herein have the capacity to resolve target RNAs down to the single-nucleotide level in vivo and can be adapted to repress translation in response to a trigger RNA. Furthermore, the loop-mediated riboregulators retain their activity in cell-free systems compatible with paper-based diagnostics, and novel computing schemes that employ loop-mediated riboregulators are useful for evaluating arbitrary Boolean logic expressions.
Accordingly, in a first aspect, provided herein is a synthetic RNA regulator having single-nucleotide polymorphism (SNP) sensitivity. Such synthetic RNA regulators are interchangeably referred to herein as “loop-mediated riboregulators” and “beacon riboregulators.” As used herein, the term “loop-mediated” refers to the presence of a large loop in the synthetic RNA regulator that, upon binding of a target RNA molecule to the loop, exposes a RBS and start codon and, thus, permits translation of the downstream gene. Furthermore, the loop-mediated mechanism is sensitive to trigger RNA interactions that perturb its original secondary structure by a small number of base pairs. It is to be understood that the invention contemplates riboregulators in their final form (e.g., comprising a coding sequence for a gene of interest) or riboregulator components (e.g., a loop-mediated cis-repressing RNA not operably linked to gene of interest).
As used herein, the terms “synthetic,” “engineered,” and “genetically engineered” are used interchangeably and refer to the aspect of having been manipulated by the hand of man. The terms encompass a non-naturally occurring nucleic acid molecule that has been created or modified by the hand of man (e.g., using recombinant DNA technology) to differ from the sequence of the nuclease as it exists in nature, or is derived from such a molecule (e.g., by transcription, translation, etc.). A nucleic acid molecule may be similar in sequence to a naturally occurring nucleic acid but typically contains at least one artificially created insertion, deletion, inversion, or substitution relative to the sequence found in its naturally occurring counterpart. A cell that contains a synthetic or engineered nucleic acid is considered to be an engineered cell. As is common practice and is understood by those in the art, progeny and copies of an engineered polynucleotide and/or polypeptide are typically still referred to as “engineered” even though the actual manipulation was performed on a prior entity.
Referring to
As used herein, the term “trigger RNA docking site” refers to a region of the loop-mediated riboregulator that is configured to bind a target or “trigger” RNA, the binding of which initiates a conformational change in the riboregulator. In some cases, the trigger RNA is an activating RNA (i.e., its presence, at a sufficient level, activates protein expression (or translation) of the coding sequence of interest). In other cases, the trigger RNA is a repressing RNA (i.e., its presence, at a sufficient level, represses protein expression or translation of the gene of interest, while expression is turned ON in the absence of the repressing trigger RNA).
In some embodiments, the stem domain comprises sequence upstream (5′) and/or downstream (3′) of the start codon. In some cases, the stem-forming domain has a length of 33 nucleotides, but in other cases will be shorter or longer than 33 nucleotides. The length of a stem-forming domain may be measured from the first pair of complementary nucleotides to the last pair of complementary bases and includes mismatched nucleotides (e.g., pairs other than AT, AU, GC), nucleotides that form a bulge, or nucleotides that form an inner loop.
In some cases, the stem-forming domain comprises nucleotides that form a bulge. Referring now to
As used herein, the term “non-complementarity” refers to refers to an entity in a double stranded region of an RNA composition (wherein the double strand nature of the RNA composition may arise from intramolecular hybridization within one RNA molecule and/or arise from intermolecular hybridization between two RNA molecules) that comprises non-complementary nucleotides between the two strands of the double stranded region. Thus, the region may be defined as a region of non-complementary nucleotides flanked by regions of double stranded RNA. In specific embodiments, the length of non-complementation is at least about 5 nucleotides. In other specific embodiments, the junction between the bubble and double stranded region comprises at least two T's. The terms “bubble” or “bulge” may also be used for the term “region of non-complementarity.” It will be understood that the terms “bubble” and “bulge” imply no specific shape of said region, although in some embodiments it is shaped as a bubble. Complementarity of two sequences is generally determined by dividing the total number of nucleotides that participate in complementary base pairs (GC, AU, AT) when the sequences are aligned to produce the maximum number of complementary base pairs, counting all nucleotides in the two sequences (including those in bulges, mismatches, or inner loops) by the total number of nucleotides contained in both sequences. For example, consider two sequences of 19 and 20 nucleotides in length in which alignment to produce the maximum number of complementary base pairs results in 16 base pairs, 1 inner loop of 2 nucleotides, 1 mismatch, and 1 bulge (in the sequence with 20 nucleotides). The percent complementarity of the two sequences is [(16+17)/39]100. It will be appreciated that complementarity may be determined with respect to the entire length of the two sequences or with respect to portions of the sequences. As used herein, two sequences are considered “substantially complementary” herein if their complementarity is at least 50%.
The advantages of the loop-mediated riboregulators described herein are multifold. First, since the trigger RNA does not interact with the bottom of the switch RNA stem, loop-mediated riboregulators can accept completely arbitrary trigger RNAs (target RNAs) without affecting the output protein sequence. Second, the loop-mediated interaction mechanism results in a system in which a similar number of base pairs exist before and after formation of the trigger/switch complex. This balance in base pairing between these two states results in very sensitive thermodynamics that can be exploited for improved device to device orthogonality and sequence discrimination down to the single-nucleotide level. Third, loop-mediated riboregulators employ a very long stem that provides transcriptional regulation with certain RNA polymerases as a result of its intrinsic termination capacity. Coupling of transcriptional and post-transcriptional regulation leads to ultralow leakage levels for loop-mediated riboregulators when used with appropriate RNA polymerases.
Nucleic acids generally refer to polymers comprising nucleotides or nucleotide analogs joined together through backbone linkages such as but not limited to phosphodiester bonds. Nucleic acids include deoxyribonucleic acids (DNA) and ribonucleic acids (RNA) such as messenger RNA (mRNA), transfer RNA (tRNA), etc. Other target nucleotide sequences include, without limitation, DNA or RNA sequences that can identify a species (e.g., ribosomal RNAs or DNAs); DNA or RNA sequences that are associated with a particular genetic condition (e.g., where the target comprises a single nucleotide polymorphism (SNP) for which PAM identification is advantageous, including, without limitation, BRCA1/BRCA2 mutations, cystic fibrosis, Duchenne muscular dystrophy, hemochromatosis); DNA or RNA sequences for identifying a particular person with high certainty (e.g., identifying a suspect in a criminal investigation; identifying a “high value target” in a military operation).
Nucleic acids may be single-stranded, double-stranded, and also tripled-stranded. The nucleic acids of the invention, including the loop-mediated riboregulator, may be provided or present in a larger nucleic acid. The larger nucleic acid may be responsible for the transcription and thus production of the loop-mediated riboregulator, as described in Example 1, for example. The larger nucleic acid may comprise a nucleotide sequence that is transcribed to produce the loop-mediated riboregulator. For convenience, the invention may refer to the larger nucleic acid as comprising the loop-mediated riboregulator although it is to be understood that in practice this intends that the larger nucleic acid comprises a sequence that encodes the loop-mediated riboregulator. Such encoding sequences may be operably linked to other sequences in the larger nucleic acid such as but not limited to origins of replication. As used herein, “operably linked” refers to a relationship between two nucleic acid sequences wherein the production or expression of one of the nucleic acid sequences is controlled by, regulated by, modulated by, etc., the other nucleic acid sequence. For example, the transcription of a nucleic acid sequence is directed by an operably linked promoter sequence; post-transcriptional processing of a nucleic acid is directed by an operably linked processing sequence; the translation of a nucleic acid sequence is directed by an operably linked translational regulatory sequence; the transport or localization of a nucleic acid or polypeptide is directed by an operably linked transport or localization sequence; and the post-translational processing of a polypeptide is directed by an operably linked processing sequence. Preferably a nucleic acid sequence that is operably linked to a second nucleic acid sequence is covalently linked, either directly or indirectly, to such a sequence, although any effective association is acceptable.
As used herein, the terms “regulatory sequence” and “regulatory element” are used interchangeably and refer to a region of nucleic acid sequence that directs, enhances, or inhibits the expression (e.g., transcription, translation, processing, etc.) of sequence(s) with which it is operatively linked. The term includes promoters, enhancers and other transcriptional and/or translational control elements. The loop-mediated riboregulator moiety may be considered to be a regulatory sequence or element to the extent it controls translation of a gene of interest that is operably linked to the loop-mediated riboregulator. The invention contemplates that the loop-mediated riboregulator may direct constitutive or inducible protein expression. Inducible protein expression may be controlled in a temporal or developmental manner.
In some cases, the loop-mediated riboregulator is operably linked to a reporter element (e.g., an E. coli lacZ reporter element encoding β-galactosidase) that is 3′ to the hairpin structure (i.e., the loop and stem domains). Reporter proteins appropriate for the methods provided herein include, without limitation, enzymatic reporters (e.g., β-galactosidase, alkaline phosphatase, DHFR, CAT), fluorescent or chemiluminescent reporters (e.g., GFP variants, mCherry, luciferase, e.g., luciferase derived from the firefly (Photinus pyralis) or the sea pansy (Renilla reniformis) and mutants thereof), etc.
Biological samples appropriate for use according to the methods provided herein include, without limitation, blood, serum, urine, saliva, tissues, cells, and organs, or portions thereof.
The nucleic acid molecule can be, e.g., an RNA, a DNA, an mRNA, and/or a genomic nucleic acid. In some embodiments of any of the aspects, the nucleic acid molecule can be human, animal, prokaryotic, eukaryotic, or pathogenic in origin. In some embodiments of any of the aspects, the nucleic acid molecule can be of viral origin. Nucleic acids and/or other moieties of the invention may be isolated. As used herein, “isolated” means separate from at least some of the components with which it is usually associated whether it is derived from a naturally occurring source or made synthetically, in whole or in part.
Nucleic acids and/or other moieties of the invention may be purified. As used herein, purified means separate from the majority of other compounds or entities. A compound or moiety may be partially purified or substantially purified. Purity may be denoted by a weight by weight measure and may be determined using a variety of analytical techniques such as but not limited to mass spectrometry, HPLC, etc.
In another aspect, provided herein are methods of altering gene expression using the synthetic nucleic acid molecules described herein. In some cases, the method alters expression of an enzyme (or other protein) in a cell and comprises introducing into a cell an enzyme coding sequence operably linked to a loop-mediated riboregulator having a trigger recognition sequence that is fully or partially complementary to an endogenous trigger RNA, whereby expression of the enzyme is altered according to the level of repressing trigger RNA introduced to the cell.
In some cases, loop-mediated riboregulators can be used to regulate expression of one or more enzymes, including entire metabolic pathways. In such cases, the method includes placing the method includes placing one or more enzymes (e.g., each enzyme in a metabolic pathway) under control of loop-mediated riboregulators that respond to the same trigger RNA. The inventors have demonstrated that the loop-mediated riboregulators provided herein yield unexpectedly high fold-change values, often in the 100-fold range. As used herein, the terms “expressing,” “expression,” or “express” refer to the production of a gene product (e.g., an mRNA transcript from a nucleic acid sequence encoding thereof). As used herein, the terms “gene product” and “expression product” generally refer to an RNA transcribed from the gene or a polypeptide encoded by an RNA transcribed from the gene. Thus a regulatory element, environmental condition, stimulus, etc., that alters the level of transcription or the stability of an RNA transcribed from a gene or alters its ability to serve as a template for translation will be said to alter expression of the gene. Similarly, a regulatory element, environmental condition, stimulus, etc., that alters the level of translation or stability of a polypeptide translated from an RNA transcribed from the gene will be said to alter expression of the gene.
In some cases, loop-mediated riboregulators are incorporated into complex, multi-input logic circuits. It is envisioned that the loop-mediated riboregulators can be incorporated into these multi-input circuits designed into computational systems for evaluating OR, AND, and conjunctive normal form (CNF) logic. For diagnostics purposes, multi-input logic circuits can be used to increase assay specificity or sensitivity. For instance, an AND or NOT-AND (“NAND”) expression can reduce false positives by ensuring that more than one pathogen-associated RNA is present in a sample. An OR or NOT-OR (“NOR”) expression can reduce false negatives by sensing more than one RNA in the same sample. In vivo, a multi-input logic circuit can be used to sense the set of RNAs produced by a prokaryote in response to environment stresses. This RNA signature can be used to modulate production of enzymes or identify cells that are susceptible to antibiotics or screen for new antibiotic compounds. In addition, the circuits that sense a set of RNAs expressed by the host could be used to generate whole-cell biosensors that detect toxic chemicals in the environment. It is envisioned that any logic circuit described herein can be used in application and methods designed to detect RNA's within a cell, either endogenous or synthetic, and that the logic circuit may be used to detect specific combination of RNAs within a cell or other biological sample.
As described herein, “AND” logic circuits are synthetic nucleic acid logic circuits comprising multiple input RNA recognition sites configured such that all input RNAs must be bound to their complementary input RNA recognition sites for expression of the target gene to occur. AND logic circuits comprise a branched secondary structure comprising two or more arms wherein a ribosomal binding site and a start codon for a target gene are located within the 3′ most arm of the branched secondary structure. Each arm of the branched secondary structure comprises a loop-domain comprising an input RNA recognition site and the separate input RNA recognition sites of the separate arms recognize unique input RNA sequences. For example, a 2-input AND circuit comprises two arms, a first 5′ arm comprising a first input RNA recognition site and a second 3′ arm comprising a second input RNA recognition site, a ribosomal binding domain and a start codon. It is envisioned that the AND logic circuit can be designed to accommodate binding of 2, 3, 4, 5, or more input RNA sequences at 2, 3, 4, 5 or more input RNA recognition sites, respectively, on 2, 3, 4, 5, or more arms, respectively. For these circuits, the input species can be RNA trigger molecules. In some embodiments, the AND circuit comprises 3 arms of a branched secondary structure and comprises 3 separate input RNA binding domains. In some embodiments, the AND circuit comprises 4 arms of a branched secondary structure and comprises 4 separate input RNA binding domains.
For all loop-mediated riboregulators described herein, the RBS and start codon are located within a stem domain. Accordingly, the term “loop domain” as used herein encompasses a stem region plus a loop region.
As described herein, “OR” logic circuits are synthetic nucleic acid logic circuits comprising multiple input RNA recognition sites configured such that only one input RNA needs to be bound to an input RNA recognition site for expression of the target gene to occur. OR logic circuits comprise a branched secondary structure wherein the stem-domain of the branched secondary structure comprises a ribosomal binding site and a start codon. The stem-domain is formed by the 5′ and 3′ ends of the branched secondary structure, and two or more arms of the branched secondary structure are located between the 5′ portion and 3′ portions which form the stem-domain. Each of the arms of the branched secondary structure comprises a loop domain which comprises an input RNA recognition site and the separate input RNA recognition sites of the separate arms recognize unique input RNA sequences. For example, for a 2-input OR circuit comprises a stem-domain and two arms, a first arm comprising first input RNA recognition site and a second arm comprising a second recognition site. In a 2-input OR expression, translation of the output gene is activated when either or both of two input species is expressed within the cell. When neither or none of the input RNA triggers is present, gene expression is turned off. It is envisioned that the OR logic circuit can be designed to accommodate binding of 2, 3, 4, 5, or more unique input RNA sequences at 2, 3, 4, 5, or more input RNA recognition sites, respectively, on 2, 3, 4, 5, or more arms, respectively. Some embodiments of the OR logic circuit are shown in
As described herein, “conjunctive normal form (CNF)” logic circuits are synthetic nucleic acid logic circuits comprising multiple input RNA recognition sites arranged in a branched secondary structure comprising two or more groups of stem-loop-domains wherein each group of stem-loop-domains comprises of two or more stem-loop-domains, wherein each stem-loop-domain comprises an input RNA recognition site. The CNF logic circuit comprises a ribosomal binding site and a start codon within the 3′ most arm of the CNF logic circuit or within the '3 most group of loop-domains. The loop-domain closes to the 3′ end of the branched secondary structure comprises the ribosomal binding site and the start codon. The branched secondary structure of the CNF circuit is configured such that for translation to occur, one or more input RNA must be bound to the RNA recognition sites within each of the two or more groups of loop-domains. For example, a 4-input CNF logic circuit comprises two groups of loop-domains and each group of loop-domains comprises two loop-domains. In the exemplary 4-input CNF logic circuit, one or more input RNA must be bound to the input RNA recognition site within each of the groups loop-domains. The CNF logic circuit is configured such that if any group of loop-domains does not have one or more input RNA bound to the input RNA recognition site, the translation of the repressed gene will remain OFF. In some embodiments, the CNF logic circuit comprises 2, 3, 4, 5, 6, or more groups of loop-domains. In some embodiments, the CNF logic circuit comprise groups of loop-domains comprising 2, 3, 4, 5, 6, or more loop-domains. Some embodiments of CNF logic circuits are shown in
Advantageously, loop-mediated riboregulators as provided herein can be designed to detect a variety of different nucleic acids such as those associated with various pathogens (e.g., viruses, parasites). In certain embodiments, the target nucleotide sequence is a nucleic acid from a pathogen, where the biological sample contains or is suspected of containing the pathogen. In some case, detecting the endogenous RNA molecule is a positive indicator of a presence of a microorganism, pathogen, or gene in a sample (e.g., a biological sample). In other cases, detecting the endogenous RNA molecule is a negative indicator of a presence of a microorganism, pathogen, or gene in a sample (e.g., a biological sample). Loop-mediated riboregulators can be designed for detection of nucleic acids from any number of microorganisms or pathogens, including those that cause or are associated with human diseases. Accordingly, the methods provided herein are useful to detect any pathogen or infectious agent. Pathogens and infectious agents may comprise viruses, (e.g., single stranded RNA viruses, single stranded DNA viruses, Zika virus, HIV, hepatitis A, B, and C virus, HSV, CMV EBV, HPV), parasites (e.g., protozoan and metazoan pathogens such as Plasmodia species, Leishmania species, Schistosoma species, Trypanosoma species), bacteria (e.g., Mycobacteria, in particular, M. tuberculosis, Salmonella, Streptococci, E. coli, Staphylococci), fungi (e.g., Candida species, Aspergillus species), Pneumocystis carinii, and prions. In certain embodiments, the pathogen is a virus, and the methods can be used to detect any virus. In other embodiments, the pathogens that are detected are bacteria, fungi, or parasites. An advantage of the methods and systems described herein is that they can be applied for the detection and identification of essentially any nucleic acid-containing organism. Accordingly, the pathogen or infectious agent can be virtually any pathogen or infectious agent for which genetic information (e.g., gene sequences) is available. In other cases, the target nucleic acid is human in origin. In such cases, the methods can be employed to detect one or more target nucleic acids in a biological sample such as a biological sample obtained for forensic analysis, for genotyping, and the like.
Microorganisms and pathogens can include, without limitation, viruses (e.g., HIV, Zika virus, norovirus, Yellow fever virus) and parasites such as the malaria parasite Plasmodium falciparum.
In some cases, it may be advantageous to adapt the methods described herein for high-throughput, reproducible, and rapid detection, for example in a clinical setting. When loop-mediated riboregulator output is coupled to a reporter element, such as a LacZ reporter element, the riboregulator acts as a genetically encoding sensor and/or imaging probe for endogenous DNA or RNA (e.g., endogenous pathogen DNA, endogenous pathogen RNA) in a sample. For example, such loop-mediated riboregulators can be provided in a device configured for rapid, reproducible detection in a clinical setting. In some cases, the device comprises a preserved paper test article, upon which any step(s) of the method provided herein can be performed. In preferred embodiments, the paper test article is preserved by freeze-drying. The reporter element can be a reporter protein, e.g., a polypeptide with an easily assayed enzymatic activity or detectable signal that is naturally absent from the host cell. Exemplary but non-limiting reporter proteins include lacZ, catalase, xylE, GFP, RFP, YFP, CFP, neomycin phosphotransferase, luciferase, mCherry, and derivatives or variants thereof. In some embodiments of any of the aspects, the reporter protein is suitable for use in a colorimetric assay. Examples of genes encoding fluorescent proteins that may be used in accordance with the invention include, without limitation, those proteins provided in U.S. Patent Application No. 2012/0003630 (see Table 59 therein), incorporated herein by reference.
In some cases, the device is used with a portable electronic reader. In this manner, the electronic reader serves as companion technology that provides robust and quantitative measurements of device outputs. An exemplary electronic reader comprises readily available consumer components, open-source code, and laser-cut acrylic housing, and is powered by a rechargeable lithium ion battery. The electronic reader can further comprise an onboard data storage unit. In some cases, to achieve sensitive detection of toehold switch signal output, an acrylic chip that holds the freeze-dried, paper-based reactions is placed into the reader between an LED light source (570 nm) and electronic sensors. Using onboard electronics, samples can be read at a rate of 29 reads per minute. Accordingly, the portable electronic reader provides low-noise measurements of changes associated with the reporter element including changes in light transmission due to LacZ-mediated color change.
As described in the Examples section, comprehensive measurements of device-to-device crosstalk have yielded a set of 15 orthogonal loop-mediated riboregulators with under 4% cross talk.
In some cases, loop-mediated riboregulators are useful in diagnostic methods. For example, repressor systems can be used in diagnostic systems for control reactions to determine if a technician is carrying out an assay properly. For instance, the loop-mediated riboregulator can be used to detect a control RNA or DNA that is amplified along with a sample from a patient. If repressor output is low, it means that the amplification reaction was successful (provided the cell-free reaction is active). If repressor output is high, it means that the amplification reaction failed but that the cell-free diagnostic stage was successful. Similarly, an activating loop-mediated riboregulator can also be used to detect a control RNA to determine if the cell-free reaction is functional when amplification is successful.
Articles of Manufacture
In another aspect, the present invention provides articles of manufacture useful for detecting a pathogen or identifying a particular strain or species of pathogen. In preferred embodiments, the article of manufacture is a kit for detecting a pathogen such as a virus, where the kit comprises a plurality of preserved paper test articles and an electronic optical reader. Optionally, a kit can further include instructions for performing the pathogen detection and/or strain or species identification methods provided herein.
Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which the invention pertains. All definitions, as defined and used herein, should be understood to control over dictionary definitions, definitions in documents incorporated by reference, and/or ordinary meanings of the defined terms.
All references, patents and patent applications disclosed herein are incorporated by reference with respect to the subject matter for which each is cited, which in some cases may encompass the entirety of the document.
The indefinite articles “a” and “an,” as used herein in the specification and in the claims, unless clearly indicated to the contrary, should be understood to mean “at least one.”
The phrase “and/or,” as used herein in the specification and in the claims, should be understood to mean “either or both” of the elements so conjoined, i.e., elements that are conjunctively present in some cases and disjunctively present in other cases. Multiple elements listed with “and/or” should be construed in the same fashion, i.e., “one or more” of the elements so conjoined. Other elements may optionally be present other than the elements specifically identified by the “and/or” clause, whether related or unrelated to those elements specifically identified. Thus, as a non-limiting example, a reference to “A and/or B”, when used in conjunction with open-ended language such as “comprising” can refer, in one embodiment, to A only (optionally including elements other than B); in another embodiment, to B only (optionally including elements other than A); in yet another embodiment, to both A and B (optionally including other elements); etc.
As used herein in the specification and in the claims, “or” should be understood to have the same meaning as “and/or” as defined above. For example, when separating items in a list, “or” or “and/or” shall be interpreted as being inclusive, i.e., the inclusion of at least one, but also including more than one, of a number or list of elements, and, optionally, additional unlisted items. Only terms clearly indicated to the contrary, such as “only one of” or “exactly one of,” or, when used in the claims, “consisting of,” will refer to the inclusion of exactly one element of a number or list of elements. In general, the term “or” as used herein shall only be interpreted as indicating exclusive alternatives (i.e. “one or the other but not both”) when preceded by terms of exclusivity, such as “either,” “one of,” “only one of,” or “exactly one of.” “Consisting essentially of,” when used in the claims, shall have its ordinary meaning as used in the field of patent law.
As used herein, the terms “approximately” or “about” in reference to a number are generally taken to include numbers that fall within a range of 5% in either direction (greater than or less than) the number unless otherwise stated or otherwise evident from the context (except where such number would exceed 100% of a possible value). Where ranges are stated, the endpoints are included within the range unless otherwise stated or otherwise evident from the context.
The present invention has been described in terms of one or more preferred embodiments, and it should be appreciated that many equivalents, alternatives, variations, and modifications, aside from those expressly stated, are possible and within the scope of the invention. The invention will be more fully understood upon consideration of the following non-limiting Examples.
Reference is now made to the following examples, which together with the above descriptions illustrate the invention in a non-limiting fashion.
This example demonstrates that, through careful design of RNA-RNA interactions, loop-mediated riboregulators have the capacity to resolve target RNAs down to the single nucleotide level in vivo and can be adapted to repress translation in response to a trigger RNA. This example also demonstrates that loop-mediated riboregulators retain their activity in cell-free systems that are compatible with paper-based diagnostics, and describes a number of novel computing schemes that employ loop-mediated riboregulators for evaluating arbitrary Boolean logic expressions.
Methods
Plasmid Construction:
Switch and trigger RNAs were expressed from separate plasmids with backbones from two vectors, pCOLADuet and pET15b, respectively. A green fluorescent protein (GFP) with an ASV degradation tag having a half-life of about 110 minutes was used as the reporter. All DNA oligonucleotides were purchased from Integrated DNA Technologies, Inc. Plasmids were assembled using the Gibson method as described previously21. Constructs were then cloned into the E. coli strain DH5a and sequenced to ensure all loop-mediated riboregulators were synthesized correctly.
Flow Cytometry Measurement and Data Analysis:
To test the loop-mediated riboregulators, competent E. coli was transformed with the desired combination of switch and trigger plasmids, and plated onto LB/agar plates containing the appropriate antibiotics. Antibiotics were used at the following concentrations: ampicillin (50 μg/ml), kanamycin (30 μg/ml). For flow cytometry measurements, LB medium containing antibiotics was inoculated with cells picked from individual colonies and incubated overnight with shaking in 96 deep well plates at 250 rpm, 37° C. Cells were then diluted 100-fold into fresh selective LB medium and returned to shaking at 37° C. Cells were then induced with 0.1 mM IPTG after shaking for 80 minutes. Measurements were done after inducing by IPTG for 3, 4, and 5 hours. IPTG induction led to production of T7 RNA polymerase. T7 RNA polymerase was in turn used to drive transcription of the trigger and switch RNAs, which were positioned downstream of the T7 promoter sequence.
Flow cytometry data were analyzed using custom Matlab scripts. In instrument settings, the threshold of events was set according to particle size, signals from particles with sizes far smaller than that of E. coli (e.g., cell debris) were removed. The E. coli populations had unimodal distributions in both forward (FSC) and side (SSC) scatter, and thus provided a single peak in the two-dimensional FSC versus SSC histogram. All ON/OFF ratios were calculated from the mode GFP fluorescence value of each sample as determined from the unimodal GFP fluorescence histogram.
Results and Discussion
Evaluating the Orthogonality of Loop-Mediated Riboregulators:
To test the orthogonality of loop-mediated riboregulators, we selected 16 different devices having relatively high ON/OFF ratios and tested all 256 pairwise combinations of switch and trigger RNAs. We used flow cytometry to quantify GFP output from all switch-trigger combinations in triplicate measurements.
The full set of 16 switches show less than 4% crosstalk, which makes them second largest set of orthogonal riboregulators reported to date21. Their crosstalk levels are slightly higher than the crosstalk of 18 toehold switches, which provided crosstalk below 2%. The higher crosstalk of loop-mediated riboregulator results from the lower average ON state expression levels for the 16 designs compared to the toehold switch library.
We evaluated the performance of loop-mediated riboregulators in cell-free, liquid-phase reactions (NEB Inc., PURExpress In vitro Protein Synthesis Kit). Plasmid DNA was used as the template for transcription of the trigger and switch RNAs and production of the output GFP reporter was monitored over time using a plate reader at a temperature of 37° C.
Stem Variants of Loop-Mediated Riboregulators:
Toehold switches add at least three amino acids between the start codon and the linker region of the regulated gene, which could have deleterious effects on the final output protein. Importantly, these extra three amino acids are encoded by the sequence of the trigger RNA that must directly replace these base pairs in the stem of the switch RNA. In contrast, for loop-mediated riboregulators, the early residues in the output gene do not directly interact with the trigger RNA and are disrupted through the crowbar-like interaction mechanism. As a result, the sequence of the trigger RNA can be completely decoupled from that output protein for loop-mediated riboregulators. However, there are 6 nucleotides located after the start codon in loop-mediated riboregulator to help maintain the system at OFF state when no cognate trigger RNA appears. We term this 6-nt a ‘clamp’ as it is designed to clamp down on leakage from the devices. We hypothesized that since the clamp does not interact directly with the trigger RNA, it should be possible to use the first 6 nucleotides of any gene as a successful clamp. To test this hypothesis, we designed four variant switches based on loop-mediated riboregulator #1. These four switches have the same sequence as #1 except inside the clamp region where the sequences are randomly designed. Then we transformed each switch with cognate trigger #1 and with one non-cognate trigger into E. coli and measured the GFP output after inducing by IPTG. The ON/OFF ratios from the mode GFP fluorescence value measured by flow cytometry are shown in
As shown in
qRT-PCR Tests of Loop-Mediated Riboregulators:
Rho-independent transcriptional terminators in prokaryotes feature long stem-loop structures that interfere with the progress of the RNA polymerase to halt transcription. While toehold switches have relatively weak stems that are 18-bp long including a 3-nt bulge, loop-mediated riboregulators have far stronger stems up to 33-nts in length. Given the strength of this stem, we hypothesized that transcriptional regulation could be playing a role in the ultralow leakage we observed in the loop-mediated riboregulators. Thus, we performed qRT-PCR studies on both loop-mediated riboregulator #1 and toehold switch N56 to determine the concentrations of the switch RNAs in vivo. We used 16s rRNA as the internal marker for the measurements. At first, we induced the expression of both cognate and non-cognate pairs of switch and trigger for loop-mediated riboregulator #1 and toehold switch N56 using three colonies for each. After induction for 3 hours, we performed RNA minipreps to extract cellular RNAs and used reverse transcription to generate cDNA. The cellular RNAs in these experiments were generated using T7 RNA polymerase in E. coli BL21 Star DE3.
The signal curves of SYBR Green from loop-mediated riboregulator #1 are shown in
These data demonstrate that a fraction of the trigger RNAs are able to bind to the newly transcribed switch RNA before the formation of the complete stem-loop structure. This binding will facilitate the transcription of the whole switch RNA including the downstream GFP gene. However, for non-cognate switch and trigger RNAs, the trigger RNA cannot bind to the newly transcribed switch RNA and a fraction of the active RNA polymerases will be displaced from the DNA due to the formation of the stable stem-loop structure. This finding demonstrates that loop-mediated riboregulators can exhibit both transcriptional and translational level regulation. To our knowledge, this is the first riboregulator reported that exploits regulation at both the transcriptional and translational levels. It is important to note that this transcriptional regulation was observed using T7 RNA polymerase, a highly active phage-derived polymerase. The behavior of the loop-mediated riboregulator may change depending on the polymerase used, the promoter driving transcription, and the RNA sequences surrounding the switch RNA module. Nevertheless, combined post-transcriptional and transcriptional regulation should be possible using similar mechanisms for other RNA polymerases using similar loop-mediated riboregulator designs.
SNP Detection with Loop-Mediated Riboregulators:
As mentioned above, loop-mediated riboregulators should be more sensitive to trigger RNA sequence changes than toehold switches, even down to the single-nucleotide level in vivo or in vitro. To test this hypothesis, we simulated computationally the interaction between switch and trigger RNAs when there is a SNP site at different positions of the trigger RNA. We also shortened the trigger length to 24-nts (down from 31-nts) and reduced the complementary region between the trigger RNA from 21-nts to 14-nts. Both these modifications helped increase the specificity of the sensor by reducing the free energy difference between the switch RNA and switch/trigger complex. The overall reaction between the trigger and switch during SNP detection disrupts 18 base pairs at the bottom of the stem while forming 14 new base pairs through binding to the loop region, yielding a net loss of 4 base pairs upon trigger binding. The extra energy driving the cognate interaction arises from the increase in entropy that occurs when the 5′ and 3′ are driven apart during trigger RNA binding. Binding of a trigger that differs by a single nucleotide will yield a net loss of 5 base pairs, an increase of 20%. In contrast, toehold switches require at least 6 new base pairs to form to provide readily detectable gene expression21 and thus exhibit much less sensitive thermodynamics. We used the NUPACK nucleic acid sequence design package to generate the binding probability of each SNP mismatch, and then selected designs with the highest sensitivity to SNP site of the trigger RNA as shown in
In the design shown in
To validate the design shown in
In
Additional studies are underway to further improve the sensitivity of these systems and reduce the signal leakage observed for devices such as those in
An Improved Design for SNP Detection Using Riboregulators:
To further improve the performance of the SNP-sensing riboregulators, we developed a novel riboregulator design that exploits competitive binding to decrease the likelihood of a non-cognate trigger RNA activating the riboregulator. As shown in
Importantly, this competitive binding system can be implemented using any riboregulator system, such as toehold switches and STARs. Improved sequence discrimination capabilities can be obtained by adding more “decoy” hairpins like the first hairpin upstream of the 3′ most riboregulator. For example, in order to detect a trigger RNA that contains the nucleotide C at the target location, one could add three decoy hairpins upstream of the riboregulator for the SNP C trigger. These decoy hairpins would be optimized to preferentially bind the SNP A, SNP U, and SNP G triggers and reduce the probability that they would be able to activate the SNP C sensing riboregulator. In addition, the decoy hairpins need not necessarily be hairpins and could simply be single-stranded binding sites of off-target sequences, provided they have similar affinities for the target RNAs as the riboregulator module downstream.
Loop-Mediated Repressors:
The riboregulators described above are designed for turning on expression of regulated genes by binding with trigger RNA. We term riboregulators that have such function “activators”. However, to precisely control gene expression and make more complex genetic circuits, riboregulators termed “repressors” has been studied by many researchers18. For repressors, gene expression in the absence of a cognate trigger RNA is initially activated and thus the repressor is in its ON state. However, when the cognate trigger RNA is expressed, binding to the riboregulator turns OFF gene expression.
To weaken the transcriptional regulation of loop-mediated riboregulator, we designed a structure containing two smaller hairpins unlikely to have rho-independent transcriptional termination activity. For the designs shown in
RNA-Only Biomolecular Logic Systems:
Synthetic biology seeks to program cellular behavior via in vivo biological circuits that are constructed from high performance orthogonal biological components. Considerable research has been focused on designing layered circuits in which the output of circuit element in one layer is fed forward into a subsequent circuit element in the next layer19. However, such layered circuit designs are limited by diffusive transport within the cytoplasm, can have hard-to-control signal propagation delays, and do not exploit the potential for parallel computation achieved by natural genetic circuits. Moreover, scale-up of layered circuit designs is difficult since the orthogonality of many circuits elements is limited, and many biological components have widely varying input and output characteristics, which can be difficult to balance within the same circuit.
One promising solution to overcome these problems is through the use of RNA-based logic gates. RNA-based logic gates take advantage of predictable Watson-Crick base pairing that is more specific and programmable than protein-DNA and protein-protein interactions, and can exhibit considerably lower crosstalk through purely in silico screening21. Moreover, RNA-based gates are easy to scale up as result of the sequence space afforded by RNA, and enable multi-input processing within a single computational layer and thus avoid the disadvantages of layered computation schemes.
To demonstrate the capacity of loop-mediated riboregulators for in vivo logic, we have devised a number of novel strategies to incorporate loop-mediated riboregulators into computational systems for evaluating OR, AND, and conjunctive normal form (CNF) logic.
We termed the RNA transcript depicted in
In order to increase the output expression from the input 1 RNA, we have also designed an RNA refolding motif shown in dark blue in
We tested the gate RNA shown in
We have also designed gates for evaluating AND logic. A 2-input AND gate design is shown in
The base 2-input OR and AND gate designs can be extended to multi-input (>2 input) gates as shown in
Combinations of OR and AND operations in conjunctive normal form (CNF) can also be evaluated using gate RNAs. A CNF expression can be described as an AND of ORs. An example of a CNF gate RNA for evaluating (A OR B) AND (C OR D) is shown in
In addition, combinations of loop-mediated riboregulators and toehold switches can be incorporated in nested fashion into gate RNAs to evaluate multi-input AND logic as shown in
This hybrid AND gate concept can be extended to arbitrary numbers of input RNA species. The secondary structure of a 3-input hybrid AND gate RNA is shown in
Compared to our previous work on RNA-only systems called ribocomputing devices (Green et al., Nature 2017, nature 23271), the loop-mediated riboregulator based logic systems and hybrid logic systems offer a number of compelling advantages. First, they have the ability to accept input RNAs for OR and AND operations with arbitrary sequences. These input RNAs can be synthetic RNAs, or endogenous or pathogenic RNAs expressed by the cells or sampled as part of an in vitro diagnostic test. Ribocomputing systems require complementarity between input RNAs involved in AND logic operations, which makes them much harder to implement for operations that require input RNAs with well-defined sequences (i.e., endogenous or pathogenic cellular RNAs, or pathogen-associated RNAs in a diagnostic).
Second, OR gates based on loop-mediated riboregulators do not require any nonsense residues to be added on to the N-terminal of the output protein. Ribocomputer OR gates and loop-mediated riboregulator AND gates add increasing numbers of nonsense residues as the number of input species increases. Third, loop-mediated riboregulator logic gates should offer improved performance for AND logic compared to ribocomputers. In ribocomputer AND logic, each input RNA is programmed to hybridize directly to the other input RNAs to form an N-molecule RNA complex for an N-input AND gate. As the number of inputs increases, an increasing fraction of incomplete reaction products are formed (e.g. 2-, 3-, . . . , and N−1-molecule RNA complexes), which leads to sharp decreases in gate performance. In contrast, for loop-mediated riboregulator AND gates, binding between the input RNAs and the gate RNA occurs in a step-by-step fashion that avoids the formation of partial products. For the expression A AND B AND C, input B can be programmed to interact with gate RNA only once input A has bound; similarly, input C only binds after the three-RNA complex A-B-gate has formed. It should be noted that input RNAs are expressed at an approximately 5- to 10-fold higher concentration than the gate RNA for the logic systems, so there is always an excess of input RNAs available to enable reactions with the gate RNA to go to completion.
Implementation of AND Gates
We have successfully implemented AND gate RNA logic devices based on loop-mediated riboregulators using in vitro cell-free reactions and in living E. coli cells. The design of an exemplary 2-input AND logic circuit tested in vitro is shown in
The 2-input AND gate RNA regulating GFP was tested in cell-free reactions in the presence of different combinations of the input RNAs (
An exemplary 2-input AND logic circuit for use in vivo is shown in
Implementation of In Vitro OR Gates
The 2-input OR gate RNA was tested in cell-free reactions with and without cognate trigger RNAs using GFP as the output protein. In the absence of cognate RNAs, low GFP expression was observed. Strong increases in GFP fluorescence, over 15-fold and 12-fold for trigger 1 and trigger 8, respectively, were observed as expected (
Digital-to-Analog RNA Devices
The RNA-based logic devices described above carry out the equivalent of digital logic in that they can adopt one of two possible binary states: ON or OFF, low or high, or 0 or 1. Typical biological systems are fundamentally analog in nature, with signals that can take on a range of values or concentrations. Systems that convert between digital and analog signals are thus essential devices for future synthetic biological circuits. One such system is a digital-to-analog converter that takes multiple binary input signals, in this case the presence or absence of an input RNA, and converts it into an analog signal, in this case protein expression level. These RNA-based digital-to-analog (DTA) systems, thus, output different protein levels depending on the precise combination of input RNAs present.
The schematic of an exemplary DTA device implemented in vitro is shown in
Pathogen Detection
The design of the loop-mediated riboregulators enables them to detect target RNAs with arbitrary sequences. We have validated several loop-mediated riboregulators that can detect nucleic acids from multiple viruses and the malaria parasite Plasmodium falciparum.
We appended a stem refolding domain on the 5′ end of the loop-mediated riboregulator switch RNAs to increase their sensitivity against natural RNAs with the potential for high secondary structure. The refolding region is shown as the blue domain in
In order to speed up detection, the alpha subunit of lacZ can be regulated using the loop-mediated riboregulators while the omega subunit of lacZ can be freeze-dried directly onto the paper (
falciparum
falciparum
Summary
In summary, this Example describes and demonstrates a novel class of riboregulators called loop-mediated riboregulators that can activate or repress gene expression in response to trigger RNAs bearing completely arbitrary sequences. Loop-mediated riboregulators provide a high degree of orthogonality, with a library of 15 devices showing cross talk levels below 4%, and routinely increase gene expression by 100-fold or more. Loop-mediated repressor systems also provide wide dynamic range of up to 90-fold. Testing of the loop-mediated riboregulators in E. coli revealed that they provide ultralow signal leakage in the absence of the trigger RNA. For the best devices, OFF state fluorescence reporter expression levels are indistinguishable from cell autofluorescence. Further evaluation of the devices through qRT-PCR revealed that this ultralow leakage is due to a new riboregulator mechanism that combines regulation at both the transcriptional and post-transcriptional level when expressed via T7 RNA polymerase. Computer-based design and optimization of loop-mediated riboregulator device parameters afforded sensors capable of resolving single base mutations in trigger RNAs and improvements in performance are likely through continued refinement and the use of competitive RNA binding sites upstream of the switch RNA hairpin. We have conceived a number of elegant approaches to incorporate loop-mediated riboregulator modules into extended gate RNAs that enable computation of OR, AND, CNF, and NOT logic operations using arbitrary RNA sequences as input molecules. These capabilities mean that loop-mediated riboregulators, in principle, will be able to evaluate arbitrary Boolean logic expressions.
The loop-mediated riboregulators provide a generalizable set of new molecular tools for programming biological systems in vivo, in vitro, and on paper. For the purposes of in vivo synthetic biology, we envision that they can be used for the construction of complex genetic circuits for evaluating arbitrary logic expressions. Furthermore, their ability to detect and respond to arbitrary RNAs means that they can be used to monitor endogenous RNA molecules expressed by the cell or those expressed upon infection by a pathogen. Detection of endogenous RNAs can be used as a means of fine-tuning gene expression for metabolic engineering; for high-throughput screening of new antibiotics, as numerous characteristic small RNAs are expressed when bacteria are subjected to stress; or for generating whole-cell biosensors. Detection of pathogenic RNAs can be used to shut down cell growth upon infection by bacteriophage and protect companies from the high costs of decontaminating their equipment following phage contamination. SNP sensing loop-mediated riboregulators can also be used to monitor the emergence of resistance conferring mutations in real-time.
For in vitro and on paper diagnostic applications, loop-mediated riboregulator based logic systems could be deployed to reduce the likelihood of false positives or false negatives. For instance, AND logic would be used to make sure that at least two RNAs associated with a pathogen are present in a sample before returning a positive test result. Similarly, OR logic could be used to provide a positive result if one or more of a set of pathogen-associated nucleic acids is detected in a sample. The ability of the loop-mediated riboregulators to detect SNPs is also very promising for future applications. There are currently many SNPs that are strongly associated with antibiotic resistance29-31, antimicrobial resistance in illnesses such as malaria32,33 and tuberculosis34, and cancer35. SNP-sensitive detectors could be used to monitor the spread and evolution of different MRSA strains30, rapidly test for antibiotic susceptibility36, slow the spread of artemisinin resistant32 strains of malaria, or provide a readout in liquid biopsies for cancer37. Importantly, all these applications could be implemented in a very low-cost, point-of-care format to enable advanced molecular diagnostics to be deployed anywhere in the world.
This application represents the national stage entry of PCT International Application No. PCT/US2017/045585, filed on Aug. 4, 2017, and, claims priority to U.S. Provisional Application No. 62/371,094, filed Aug. 4, 2016, each of which is incorporated herein by reference as if set forth in its entirety.
| Filing Document | Filing Date | Country | Kind |
|---|---|---|---|
| PCT/US2017/045585 | 8/4/2017 | WO |
| Publishing Document | Publishing Date | Country | Kind |
|---|---|---|---|
| WO2018/027177 | 2/8/2018 | WO | A |
| Number | Name | Date | Kind |
|---|---|---|---|
| 20050153282 | Linnen et al. | Jul 2005 | A1 |
| 20190071737 | Green | Mar 2019 | A1 |
| 20190185856 | Green | Jun 2019 | A1 |
| 20190256898 | Green | Aug 2019 | A1 |
| 20190276901 | Green | Sep 2019 | A1 |
| 20190285620 | Green | Sep 2019 | A1 |
| Number | Date | Country |
|---|---|---|
| 2012058488 | May 2012 | WO |
| 2014074648 | May 2014 | WO |
| 2016011089 | Jan 2016 | WO |
| 2017147585 | Aug 2017 | WO |
| 2017205668 | Nov 2017 | WO |
| 2018026762 | Feb 2018 | WO |
| 2018026765 | Feb 2018 | WO |
| 2018075502 | Apr 2018 | WO |
| 2018093898 | May 2018 | WO |
| 2018112350 | Jun 2018 | WO |
| 2018187687 | Oct 2018 | WO |
| Entry |
|---|
| Ma et al. (Nature Biomedical Engineering, 2022 vol. 6:298-309). |
| International Search Report and Written Opinion for International Patent Application No. PCT/US2017/045585 dated Oct. 25, 2017. |
| Green et al., “Toehold Swtiches: De-Novo-Designed Regulators of Gene Expression,” Cell, Oct. 23, 2014 (23.10.214), vol. 159. No. 4, pp. 925-939, entire document. |
| Green et al., “Complex cellular logic computation using ribocomputing devices.” Nature, Jul. 26, 2017 (Jul. 26, 2017), vol. 548, No. 7665, pp. 117-121, entire document. |
| Auslander S., et al, “Programmable single-cell mammalian biocomputers,” Nature 487, 123-+ (2012). |
| Barczak A. K., et al, “RNA signatures allow rapid identification of pathogens and antibiotic susceptibilities,” Proceedings of the National Academy of Sciences 109, 6217-6222 (2012). |
| Brantl, S. et al., “Antisense RNA-mediated transcriptional attenuation: an in vitro study of plasmid pT181,” Molecular Microbiology 35, 1469-1482 (2000). |
| Callura, J. M. et al, “Genetic switchboard for synthetic biology applications,” P Natl Acad Sci USA 109, 5850-5855 (2012). |
| Callura, J. M. et al, “Tracking, tuning, and terminating microbial physiology using synthetic riboregulators,” P Natl Acad Sci USA 107, 15898-15903 (2010). |
| Chappell J., et al., “Creating small transcription activating RNAs,” Nat. Chem. Biol. 11, 214-220 (2015). |
| Daniel R., et al, “Synthetic analog computation in living cells,” Nature 497, 619-+ (2013). |
| Elowitz M. B. et al “A synthetic oscillatory network of transcriptional regulators,” Nature 403, 335-338 (2000). |
| Figueiredo P., et al, “Prevalence of pfmdrl, pfcrt, pfdhfr and pfdhps mutations associated with drug resistance, in Luanda, Angola,” Malaria journal 7, 236 (2008). |
| Friedland A. E., et al, “Synthetic Gene Networks That Count,” Science 324, 1199-1202 (2009). |
| Gardner, T.S., et al, “Construction of a genetic toggle switch in Escherichia coli,” Nature 403, 339-342 (2000). |
| Green A. A., et al, “Toehold Switches: De-Novo-Designed Regulators of Gene Expression,” Cell 159, 925-939 (2014). |
| Gultyaev A. P., et al, “Programmed cell death by hok/sok of plasmid R1: Coupled nucleotide covariations reveal a phylogenetically conserved folding pathway in the hok family of mRNAs,” J. Mol. Biol. 273, 26-37 (1997). |
| Saacs F. J. et al, “Engineered riboregulators enable post-transcriptional control of gene expression,” Nat. Biotechnol. 22, 841-847 (2004). |
| Jansson M. D. et al, “MicroRNA and cancer,” Molecular Oncology 6, 590-610 (2012). |
| Karachaliou N., et al, “Real-time liquid biopsies become a reality in cancer treatment,” Annals of Translational Medicine 3 (2015). |
| Khalil A. S., et al, “Synthetic biology: applications come of age,” Nat Rev Genet 11, 367-379 (2010). |
| Lucks J.B., et al, “Versatile RNA-sensing transcriptional regulators for engineering genetic networks,” Proc. Natl. Acad. Sci. U.S.A. 108, 8617-8622 (2011). |
| McArthur A. G., et al, “The Comprehensive Antibiotic Resistance Database,” Antimicrobial Agents and Chemotherapy 57, 3348-3357 (2013). |
| McDonald, M. et al, “Use of a Single- Nucleotide Polymorphism Genotyping System to Demonstrate the Unique Epidemiology of Methicillin-Resistant Staphylococcus aureus in Remote Aboriginal Communities,” Journal of Clinical Microbiology 44, 3720-3727 (2006). |
| Moon, T.S., et al, “Genetic programs constructed from layered logic gates in single cells,” Nature 491, 249-253 (2012). |
| Mutalik, V. K., et al, “Rationally designed families of orthogonal RNA regulators of translation,” Nat. Chem. Biol. 8, 447-454 (2012). |
| Pardee K. et al, “Paper-Based Synthetic Gene Networks,” Cell 159, 940-954 (2014). |
| Pardee K., et al, “Rapid, Low-Cost Detection of Zika Virus Using Programmable Biomolecular Components,” Cell 165, 1255-1266 (2016). |
| Purnick P. E. M., et al, “The second wave of synthetic biology: from modules to systems,” Nat Rev Mol Cell Bio 10, 410-422 (2009). |
| Rodrigo G., et al, “De novo automated design of small RNA circuits for engineering synthetic riboregulation in living cells,” P Natl Acad Sci USA 109, 15271-15276 (2012). |
| Siuti P., et al, “Synthetic circuits integrating logic and memory in living cells,” Nat Biotechnol 31, 448-+ (2013). |
| Stephens A. J., et al, “Methicillin-resistant Staphylococcus aureus genotyping using a small set of polymorphisms,” Journal of medical microbiology 55, 43-51 (2006). |
| Takahashi M. K., et al, “A modular strategy for engineering orthogonal chimeric RNA transcription regulators,” Nucleic Acids Res. 41, 7577-7588 (2013). |
| Tyagi S, et al, “Molecular beacons: Probes that fluoresce upon hybridization,” Nat Biotechnol 14, 303-308 (1996). |
| Wang Z., et al, “Prevalence of K13-propeller polymorphisms in Plasmodium falciparum from China- Myanmar border in 2007-2012,” Malaria journal 14, 168 (2015). |
| Win M. N., et al, “Higher-order cellular information processing with synthetic RNA devices,” Science 322, 456-460 (2008). |
| Winkler W., et al, “Thiamine derivatives bind messenger RNAs directly to regulate bacterial gene expression,” Nature 419, 952-956 (2002). |
| Xie Z, et al, “Multi-Input RNAi-Based Logic Circuit for Identification of Specific Cancer Cells,” Science 333, 1307-1311 (2011). |
| Yao C, et al, “Detection of rpoB, katG and inhA gene mutations in Mycobacterium tuberculosis clinical isolates from Chongqing as determined by microarray,” Clin Microbiol Infec 16, 1639-1643 (2010). |
| Zadeh J. N., et al, “NUPACK: Analysis and Design of Nucleic Acid Systems,” J Comput Chem 32, 170-173 (2011). |
| Zhang D. Y., et al, “Optimizing the specificity of nucleic acid hybridization,” Nat Chem 4, 208-214 (2012). |
| U.S. Appl. No. 16/303,937. |
| U.S. Appl. No. 16/322,719. |
| U.S. Appl. No. 16/349,752. |
| U.S. Appl. No. 16/468,846. |
| U.S. Appl. No. 16/603,338. |
| U.S. Appl. No. 16/245,984. |
| Number | Date | Country | |
|---|---|---|---|
| 20190218624 A1 | Jul 2019 | US |
| Number | Date | Country | |
|---|---|---|---|
| 62371094 | Aug 2016 | US |
